Deerland Probiotics & Enzymes Announces Acquisition
of Bifodan A/S

November 4, 2019 | News, Press release

Acquisition Gives Deerland a Larger Global Footprint

FOR IMMEDIATE RELASE.

KENNESAW, GA (October 31, 2019) – Deerland Probiotics & Enzymes, a US-based supplier of sciencebacked solutions for microbiome health, announced today its acquisition of Bifodan A/S. Bifodan, based in Hundested, Denmark, is a life science company specialized in developing, manufacturing and distributing unique probiotic product solutions as private label dietary supplements, medical devices and OTC drugs.

Effective with the acquisition, Bifodan is now a wholly-owned subsidiary of Deerland Probiotics & Enzymes, Inc. Deerland’s Scott Ravech will continue in his role as CEO with global oversight of the newly combined company. Bifodan’s current CEO, Steen Andersen, has been named President Deerland Probiotics and Enzymes International for the combined company and will be responsible for the Hundested site and all activities outside the Americas.

“We believe this investment will allow us to bring even greater value to our respective customers and to the enzyme and probiotic industries we serve,” said Ravech.

Deerland and Bifodan are both focused on providing innovative, scientifically-sound formulation and development services.

‘We are excited to join the Deerland organization and have great expectations to leverage the combined competencies of our companies to create a strong global player’ stated Andersen.

The acquisition of Bifodan gives Deerland a larger global footprint, and highlights the company’s commitment to its vision for all people of all cultures to benefit from its enzyme, probiotic and prebiotic health products. “Deerland and Bifodan are leaders in their respective markets. Bringing together this expertise will benefit both companies, our employees, and our customers,” Ravech said.

 

About Deerland Probiotics & Enzymes
Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology. The company offers a line of unique, clinically supported branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast® and Glutalytic®. Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement and food and beverage markets. In addition to branded ingredients and customized formulations, Deerland offers full turn key manufacturing services, including bulk blends, capsules, stick packs and tablets; as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.Deerland.com.

About Bifodan A/S
Bifodan A/S develops and manufactures probiotic turnkey solutions for private label customers worldwide. Based just North of Copenhagen, Denmark, Bifodan delivers clinically documented, highquality probiotic products, manufactured at a GMP approved production facility. Bifodan has a long history in probiotic bacteria, as the company was founded by the first Danish dairy to isolate the lactobacillus acidophilus bacteria in 1938. Bifodan has been dedicated to research and development of probiotic nutritional supplements since 1992

Download Press Release
For further information please contact:

Mr. Steen Andersen
President & CEO Bifodan
Phone: +45 3163 7901
E-mail: sta@bifodan.com

Mrs. Susanne Baekgaard
Vice President Marketing Bifodan
Phone: +45 3163 7918
E-mail: sab@bifodan.com